Roberto, A., Di Vito, C., Zaghi, E., Mazza, E. M. C., Capucetti, A., Calvi, M., . . . Mavilio, D. (2018). The early expansion of anergic NKG2A(pos)/CD56(dim)/CD16(neg) natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation. Haematologica.
Chicago Style citaatRoberto, Alessandra, et al. "The Early Expansion of Anergic NKG2A(pos)/CD56(dim)/CD16(neg) Natural Killer Represents a Therapeutic Target in Haploidentical Hematopoietic Stem Cell Transplantation." Haematologica 2018.
MLA citatieRoberto, Alessandra, et al. "The Early Expansion of Anergic NKG2A(pos)/CD56(dim)/CD16(neg) Natural Killer Represents a Therapeutic Target in Haploidentical Hematopoietic Stem Cell Transplantation." Haematologica 2018.